ENZON PHARMACEUTICALS INC (ENZN) Financials
ENZN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 47.0 million | 44.5 million |
| 2023-06-30 | 46.7 million | 402000 |
| 2023-03-31 | 46.5 million | 43.4 million |
| 2022-12-31 | 47.6 million | 1.7 million |
ENZN Free Cash Flow and Stock based compensation
No data available :(
ENZN Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2023-09-30 | 321000 |
| 2023-06-30 | 183000 |
| 2023-03-31 | 197000 |
| 2022-12-31 | 333000 |
ENZN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | - | - | - |
| 2023-06-30 | - | - | - |
| 2023-03-31 | - | - | - |
| 2022-12-31 | - | - | - |
ENZN Shares Outstanding
ENZN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | - | 225000 | - |
| 2023-06-30 | - | - | 318000 | - |
| 2023-03-31 | - | - | 285000 | - |
| 2022-12-31 | - | - | 237000 | - |
ENZN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | - |
| 2023-06-30 | - | - |
| 2023-03-31 | - | - |
| 2022-12-31 | 26000 | - |
ENZN
Price: $0.08
52 week price:
Earnings Per Share: -0.01 USD
P/E Ratio: -9
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 5587
Market Capitalization: 5.6 million
Average Dividend Frequency: 1